Kisely Steve R, Campbell Leslie Anne, Yelland Michael J, Paydar Anita
School of Population Health, The University of Queensland, Brisbane,
Cochrane Database Syst Rev. 2012 Jun 13(6):CD004101. doi: 10.1002/14651858.CD004101.pub4.
Recurrent chest pain in the absence of coronary artery disease is a common problem that sometimes leads to excess use of medical care. Although many studies examine the causes of pain in these patients, few clinical trials have evaluated treatment. The studies reviewed in this paper provide an insight into the effectiveness of psychological interventions for this group of patients.
To update the previously published systematic review.
We searched the Cochrane LIbrary (CENTRAL and DARE) (Issue 3 of 4 2011), MEDLINE (1966 to August Week 5, 2011), CINAHL (1982 to Sept 2011) EMBASE (1980 to Week 35 2011), PsycINFO (1887 to Sept Week 1, 2011), and Biological Abstracts (January 1980 to Sept 2011). We also searched citation lists and approached authors.
Randomised controlled trials (RCTs) with standardised outcome methodology that tested any form of psychotherapy for chest pain with normal anatomy. Diagnoses included non-specific chest pain (NSCP), atypical chest pain, syndrome X, or chest pain with normal coronary anatomy (as either inpatients or outpatients).
Two authors independently selected studies for inclusion, extracted data and assessed quality of studies. The authors contacted trial authors for further information about the RCTs included.
Six new RCTs were located and added to the existing trials, therefore, a total of 15 RCTs (803 participants) were included. There was a significant reduction in reports of chest pain in the first three months following the intervention; fixed-effect relative risk = 0.68 (95% CI 0.57 to 0.81). This was maintained from three to nine months afterwards; relative risk = 0.59 (95% CI 0.45 to 0.76). There was also a significant increase in the number of chest pain free days up to three months following the intervention; mean difference = 2.81 (95% CI 1.28 to 4.34). This was associated with reduced chest pain frequency (random-effects mean difference = -2.26 95% CI -4.41 to -0.12) but there was no evidence of effect of treatment on chest pain frequency from three to twelve months (random-effects mean difference -0.81 95% CI -2.35, 0.74). There was no effect on severity (random-effects mean difference = -4.64 (95% CI -12.18 to 2.89) up to three months after the intervention. Overall there was generally a low risk of bias, however, there was high heterogeneity and caution is required in interpreting these results. Wide variability in outcome measures made integration of studies for secondary outcome measures difficult to report on.
AUTHORS' CONCLUSIONS: This review suggests a modest to moderate benefit for psychological interventions, particularly those using a cognitive-behavioural framework, which was largely restricted to the first three months after the intervention. Hypnotherapy is also a possible alternative. The evidence for brief interventions was less clear. Further RCTs of psychological interventions for NSCP with follow-up periods of at least 12 months are needed.
在无冠状动脉疾病的情况下反复出现胸痛是一个常见问题,有时会导致医疗资源的过度使用。尽管许多研究探讨了这些患者疼痛的原因,但很少有临床试验评估治疗方法。本文所综述的研究为心理干预对这组患者的有效性提供了见解。
更新之前发表的系统评价。
我们检索了Cochrane图书馆(CENTRAL和DARE)(2011年第4期第3卷)、MEDLINE(1966年至2011年8月第5周)、CINAHL(1982年至2011年9月)、EMBASE(1980年至2011年第35周)、PsycINFO(1887年至2011年9月第1周)以及生物学文摘(1980年1月至2011年9月)。我们还检索了参考文献列表并联系了作者。
采用标准化结局方法的随机对照试验(RCT),测试针对解剖结构正常的胸痛的任何形式心理治疗。诊断包括非特异性胸痛(NSCP)、非典型胸痛、X综合征或冠状动脉解剖结构正常的胸痛(住院患者或门诊患者)。
两位作者独立选择纳入研究、提取数据并评估研究质量。作者联系试验作者以获取有关纳入的RCT的更多信息。
找到六项新RCT并将其添加到现有试验中,因此,共纳入15项RCT(803名参与者)。干预后前三个月胸痛报告显著减少;固定效应相对风险=0.68(95%可信区间0.57至0.81)。此后三至九个月保持这一结果;相对风险=0.59(95%可信区间0.45至0.76)。干预后三个月内无痛天数也显著增加;均值差=2.81(95%可信区间1.28至4.34)。这与胸痛频率降低相关(随机效应均值差=-2.26,95%可信区间-4.41至-0.12),但在三至十二个月期间没有证据表明治疗对胸痛频率有影响(随机效应均值差=-0.81,95%可信区间-2.35至0.74)。干预后三个月内对严重程度无影响(随机效应均值差=-4.64(95%可信区间-12.18至2.89))。总体而言,偏倚风险一般较低,然而,异质性较高,解释这些结果时需谨慎。结局测量的广泛变异性使得难以报告次要结局测量的研究合并情况。
本综述表明心理干预有适度至中度益处,特别是那些采用认知行为框架的干预,这种益处主要局限于干预后的前三个月。催眠疗法也是一种可能的选择。简短干预的证据不太明确。需要进行至少12个月随访期的NSCP心理干预的进一步RCT。